Skip to main content

Eribulin Mesylate

Therapy Area
Anti-Cancer/ Oncology
API Technology
Synthetic
Formulation
Injectable
Development Status
Under-Development
Innovator Brand (US)
HALAVEN

We are here to help, if you have any country specific requirements - please Contact Us.